CIK 0001553643 · Non-accelerated filer<br>Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 455401931
- Phone
- 646 876 3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Ence Chuck CA and CO | Purchase | +13,670 | $4.05 | $55K | 38,970 |
| 2024-01-30 | TRAVERSA SERGIO Chief Executive Officer | Purchase | +40,999 | $3.90 | $160K | 216,564 |
| 2024-01-30 | Shenouda Maged Chief Financial Officer | Purchase | +15,000 | $3.89 | $58K | 28,028 |
| 2024-01-30 | Ence Chuck CA and CO | Purchase | +14,500 | $3.87 | $56K | 25,300 |
| 2024-01-29 | TRAVERSA SERGIO Chief Executive Officer | Purchase | +31,541 | $3.71 | $117K | 175,565 |
| 2024-01-29 | Shenouda Maged Chief Financial Officer | Purchase | +10,800 | $3.65 | $39K | 13,028 |
| 2024-01-29 | Ence Chuck CA and CO | Purchase | +10,800 | $3.65 | $39K | 10,800 |
| 2023-12-15 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Stock Option (right to buy) | +183,881 | 183,881 | ||
| 2023-12-15 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +82,090 | 82,090 | ||
| 2023-12-15 | Kelly Paul Edward Director | Grant or award · Stock Option (right to buy) | +65,672 | 65,672 | ||
| 2023-12-15 | GLASSPOOL JOHN Director | Grant or award · Stock Option (right to buy) | +31,522 | 31,522 | ||
| 2023-12-15 | Fedeli Fabiana Director | Grant or award · Stock Option (right to buy) | +31,522 | 31,522 | ||
| 2023-12-15 | Ence Chuck Chief Accounting and CO | Grant or award · Stock Option (right to buy) | +82,090 | 82,090 | ||
| 2023-12-15 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (right to buy) | +31,522 | 31,522 | ||
| 2023-05-25 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Stock Option (right to buy) | +527,211 | 850,728 | ||
| 2023-05-25 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +317,643 | 512,560 | ||
| 2023-05-25 | SCHMIDT ERIC THOMAS Director | Grant or award · Stock Option (right to buy) | +92,958 | 150,000 | ||
| 2023-05-25 | Kelly Paul Edward Director | Grant or award · Stock Option (right to buy) | +92,958 | 150,000 | ||
| 2023-05-25 | GLASSPOOL JOHN Director | Grant or award · Stock Option (right to buy) | +92,958 | 150,000 | ||
| 2023-05-25 | Fedeli Fabiana Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 |
Page 4 of 9 · 178 trades